175 related articles for article (PubMed ID: 11880957)
21. Antibiotic-resistant bloodstream infections in hospitalized patients: specific risk factors in a high-risk population?
von Baum H; Ober JF; Wendt C; Wenzel RP; Edmond MB
Infection; 2005 Oct; 33(5-6):320-6. PubMed ID: 16258861
[TBL] [Abstract][Full Text] [Related]
22. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.
Weinstock DM; Conlon M; Iovino C; Aubrey T; Gudiol C; Riedel E; Young JW; Kiehn TE; Zuccotti G
Biol Blood Marrow Transplant; 2007 May; 13(5):615-21. PubMed ID: 17448922
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin-resistant enterococcal bacteremia.
Boyce JM
Clin Infect Dis; 2002 Dec; 35(11):1445-6; discsussion 1446. PubMed ID: 12439814
[No Abstract] [Full Text] [Related]
24. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia.
Price CS; Paule S; Noskin GA; Peterson LR
Clin Infect Dis; 2003 Oct; 37(7):921-8. PubMed ID: 13130403
[TBL] [Abstract][Full Text] [Related]
25. [Emergency of vancomycin-resistant Enterococcus infections in a teaching hospital in Chile].
Fica A; Jemenao MI; Bilbao P; Ruiz G; Sakurada A; Pérez de Arce E; Zúñiga I; Gompertz M
Rev Chilena Infectol; 2007 Dec; 24(6):462-71. PubMed ID: 18180821
[TBL] [Abstract][Full Text] [Related]
26. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections.
Joels CS; Matthews BD; Sigmon LB; Hasan R; Lohr CE; Kercher KW; Norton J; Sing RF; Heniford BT
Am Surg; 2003 Jun; 69(6):514-9. PubMed ID: 12852510
[TBL] [Abstract][Full Text] [Related]
28. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
[TBL] [Abstract][Full Text] [Related]
29. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR
Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151
[TBL] [Abstract][Full Text] [Related]
30. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.
Sakka V; Tsiodras S; Galani L; Antoniadou A; Souli M; Galani I; Pantelaki M; Siafakas N; Zerva L; Giamarellou H
Clin Microbiol Infect; 2008 Jan; 14(1):14-21. PubMed ID: 18005178
[TBL] [Abstract][Full Text] [Related]
31. Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia?
Krcmery V; Bilíková E; Svetlansky I; Kovacicová G
Clin Infect Dis; 2001 Apr; 32(7):1110-2. PubMed ID: 11264043
[No Abstract] [Full Text] [Related]
32. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.
Gearhart M; Martin J; Rudich S; Thomas M; Wetzel D; Solomkin J; Hanaway MJ; Aranda-Michel J; Weber F; Trumball L; Bass M; Zavala E; Steve Woodle E; Buell JF
Clin Transplant; 2005 Dec; 19(6):711-6. PubMed ID: 16313314
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
Worth LJ; Thursky KA; Seymour JF; Slavin MA
Eur J Haematol; 2007 Sep; 79(3):226-33. PubMed ID: 17655696
[TBL] [Abstract][Full Text] [Related]
34. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
[TBL] [Abstract][Full Text] [Related]
35. [Bacteremia caused by Enterococcus gallinarum with a high level of glycopeptide resistance: 1st documented cases in Argentina].
Togneri A; Lopardo H; Corso A
Rev Argent Microbiol; 2003; 35(2):96-9. PubMed ID: 12920991
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
Pelz RK; Lipsett PA; Swoboda SM; Diener-West M; Powe NR; Brower RG; Perl TM; Hammond JM; Hendrix CW
Intensive Care Med; 2002 Jun; 28(6):692-7. PubMed ID: 12107672
[TBL] [Abstract][Full Text] [Related]
37. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave V; Garcia-Diaz J; Islam T; Hasbun R
J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
[TBL] [Abstract][Full Text] [Related]
40. Recurrent vancomycin-resistant Enterococcus bacteremia: prevalence, predisposing factors, and strain relatedness.
Baran J; Riederer KM; Ramanathan J; Khatib R
Clin Infect Dis; 2001 May; 32(9):1381-3. PubMed ID: 11303278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
